- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/02 - Peptides of undefined number of amino acidsDerivatives thereof
Patent holdings for IPC class A61K 38/02
Total number of patents in this class: 1200
10-year publication summary
71
|
117
|
119
|
112
|
72
|
76
|
76
|
61
|
54
|
42
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19961 |
22 |
MAPI Pharma Ltd. | 84 |
16 |
Massachusetts Institute of Technology | 10062 |
13 |
Cornell University | 3307 |
12 |
N.V. Nutricia | 1062 |
11 |
The Johns Hopkins University | 5675 |
10 |
The General Hospital Corporation | 4740 |
10 |
Yale University | 2394 |
10 |
Acceleron Pharma Inc. | 360 |
9 |
Société des Produits Nestlé S.A. | 9289 |
8 |
President and Fellows of Harvard College | 5986 |
8 |
Amicrobe, Inc. | 18 |
8 |
Children's Medical Center Corporation | 1876 |
8 |
Osaka University | 3379 |
8 |
Yeda Research and Development Co. Ltd. | 1339 |
8 |
Betterlife Pharma US Inc. | 9 |
8 |
The Board of Trustees of the Leland Stanford Junior University | 6428 |
7 |
Board of Regents, The University of Texas System | 5808 |
7 |
Northwestern University | 3398 |
7 |
Enterprise Science Fund, LLC | 134 |
7 |
Other owners | 1003 |